Brief: Kalvista Pharmaceuticals Announces Proposed Offering Of $110.0 Million Of Convertible Senior Notes
24/09/2025 23:19
Sept 24 (Reuters) - Kalvista Pharmaceuticals Inc KALV.O: KALVISTA PHARMACEUTICALS ANNOUNCES PROPOSED OFFERING OF $110.0 MILLION OF CONVERTIBLE SENIOR NOTES KALVISTA PHARMACEUTICALS INC - PROCEEDS TO FUND WORKING CAPITAL AND EKTERLY COMMERCIALIZATION KALVISTA PHARMACEUTICALS INC - NOTES MATURE ON OCTOBER 1, 2031 Source text: ID:nBw6BlZTJa Further company coverage: KALV.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kalvista Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 08:36 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Seagate, GE Healthcare, Bloom Energy